BTCY
Biotricity, Inc. [BTCY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BTCY Stock Summary
Top 10 Correlated ETFs
BTCY
Top 10 Correlated Stocks
BTCY
In the News
BTCY Financial details
Company Rating
-
Market Cap
10.65M
Income
-14.58M
Revenue
11.63M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
55
Optionable
No
Shortable
Yes
Earnings
28 Jun 2024
P/E
-0.57
Forward P/E
-
PEG
0.1
P/S
0.86
P/B
-0.38
P/C
-
P/FCF
-1.03
Quick Ratio
0.17
Current Ratio
0.29
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.66
EPS next Y
-
EPS next Q
-
EPS this Y
-44.16%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.9%
Revenue last 5Y
89.14%
Revenue Q/Q
2.82%
EPS Q/Q
-26.19%
-
-
-
-
SMA20
42.5%
SMA50
103.57%
SMA100
119.23%
Inst Own
-
Inst Trans
-
ROA
-248%
ROE
80%
ROC
1.08%
Gross Margin
62%
Oper. Margin
-107%
Profit Margin
-152%
Payout
-1%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.469-3.784
52W High
-
52W Low
-
RSI
53.63
Rel Volume
0.23
Avg Volume
78.51K
Volume
17.88K
Perf Week
-20.8%
Perf Month
43.78%
Perf Quarter
69.54%
Perf Half Y
43.35%
-
-
-
-
Beta
1.537
-
-
Volatility
0.04%, 0.12%
Prev Close
6.04%
Price
0.5544
Change
3.63%
Company Profile
- Volume Average 78.51K
- Market Capitalization 10.65M
- Employee 55
- CEO Dr. Waqaas Al-Siddiq Ph.D.
- Headquarters Redwood City,CA,US
- IPO Date 2018-02-16
-
Website
https://www.biotricity.com 
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
